Wednesday, February 08, 2012 1:59:35 AM
Yes, we do have a character with a not-so-great (ok, terrible) history on board here.. Nevertheless, I find the OTS products to be extremely promising. I added to my position at .014 today.
It's also worth mentioning that this is also the second time we have shot back up after sinking into sub-penny territory. It does seem that it should be a relatively safe buy in this area (you know what I mean by relatively -- I highly doubt we're on the fast track south to .0001 like some have previously stated).
LifeCradle HR is something that has been in the works for a very long time, and it has been stated that it will enter clinical trials this year. It has already proven that it works extremely well when compared to the traditional static preservation techniques, and it has indeed been tested with human hearts already. So, it does seem like a great technology they have come up with, and to me it is just as exciting as the HPV test.
So, let's hang on for the ride.. we don't know what tomorrow will bring, but hopefully we'll get some news and will be able to take part in one heck of a run..
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM